vs
EOG资源（GURE）与Profound Medical Corp.（PROF）财务数据对比。点击上方公司名可切换其他公司
EOG资源的季度营收约是Profound Medical Corp.的1.5倍（$9.0M vs $6.0M），Profound Medical Corp.净利率更高（-136.8% vs -394.3%，领先257.6%）
EOG资源是一家美国能源企业，主营业务为油气勘探开发。公司注册于特拉华州，总部位于德克萨斯州休斯顿的传统广场大厦，是美国本土重要的独立油气生产商之一。
康派集团医疗SE & Co. KGaA是一家总部位于德国科布伦茨的上市软件企业，专注于为医疗领域开发并提供相关软件产品，面向诊所、药房、医学实验室与医院推出支持诊疗及运营工作的云化数字应用软件。截至2022年，该公司全球员工规模超9200人，业务覆盖56个国家，拥有超过160万用户。
GURE vs PROF — 直观对比
营收规模更大
GURE
是对方的1.5倍
$6.0M
净利率更高
PROF
高出257.6%
-394.3%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $9.0M | $6.0M |
| 净利润 | $-35.7M | $-8.2M |
| 毛利率 | — | 66.8% |
| 营业利润率 | -3.7% | -123.3% |
| 净利率 | -394.3% | -136.8% |
| 营收同比 | 303.4% | — |
| 净利润同比 | -921.1% | — |
| 每股收益（稀释后） | — | $0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GUREPROF
| Q4 25 | — | $6.0M | ||
| Q3 25 | $9.0M | $5.1M | ||
| Q2 25 | $8.3M | $2.0M | ||
| Q1 25 | — | $2.3M | ||
| Q4 23 | $6.9M | — | ||
| Q3 23 | $5.9M | — | ||
| Q2 23 | $8.0M | — | ||
| Q1 23 | $9.3M | — |
净利润GUREPROF
| Q4 25 | — | $-8.2M | ||
| Q3 25 | $-35.7M | $-8.0M | ||
| Q2 25 | $-773.8K | $-15.7M | ||
| Q1 25 | — | $-10.7M | ||
| Q4 23 | $-58.8M | — | ||
| Q3 23 | $-1.8M | — | ||
| Q2 23 | $-681.8K | — | ||
| Q1 23 | $-557.7K | — |
毛利率GUREPROF
| Q4 25 | — | 66.8% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 81.7% | ||
| Q1 25 | — | 79.2% | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | 8.5% | — | ||
| Q1 23 | 27.2% | — |
营业利润率GUREPROF
| Q4 25 | — | -123.3% | ||
| Q3 25 | -3.7% | -176.2% | ||
| Q2 25 | -9.0% | -696.9% | ||
| Q1 25 | — | -477.0% | ||
| Q4 23 | -114.7% | — | ||
| Q3 23 | -39.1% | — | ||
| Q2 23 | -11.5% | — | ||
| Q1 23 | -8.6% | — |
净利率GUREPROF
| Q4 25 | — | -136.8% | ||
| Q3 25 | -394.3% | -157.7% | ||
| Q2 25 | -9.3% | -792.3% | ||
| Q1 25 | — | -458.1% | ||
| Q4 23 | -855.6% | — | ||
| Q3 23 | -30.3% | — | ||
| Q2 23 | -8.5% | — | ||
| Q1 23 | -6.0% | — |
每股收益（稀释后）GUREPROF
| Q4 25 | — | $0.27 | ||
| Q3 25 | — | $0.26 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.36 | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $59.7M |
| 总债务越低越好 | — | $4.5M |
| 股东权益账面价值 | $107.5M | $66.4M |
| 总资产 | $131.9M | $77.5M |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资GUREPROF
| Q4 25 | — | $59.7M | ||
| Q3 25 | — | $24.8M | ||
| Q2 25 | — | $35.2M | ||
| Q1 25 | — | $46.4M | ||
| Q4 23 | $72.2M | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
总债务GUREPROF
| Q4 25 | — | $4.5M | ||
| Q3 25 | — | $4.5M | ||
| Q2 25 | — | $4.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
股东权益GUREPROF
| Q4 25 | — | $66.4M | ||
| Q3 25 | $107.5M | $32.1M | ||
| Q2 25 | $142.2M | $39.3M | ||
| Q1 25 | — | $50.8M | ||
| Q4 23 | $205.2M | — | ||
| Q3 23 | $260.7M | — | ||
| Q2 23 | $260.3M | — | ||
| Q1 23 | $274.8M | — |
总资产GUREPROF
| Q4 25 | — | $77.5M | ||
| Q3 25 | $131.9M | $42.3M | ||
| Q2 25 | $164.6M | $49.7M | ||
| Q1 25 | — | $60.9M | ||
| Q4 23 | $226.7M | — | ||
| Q3 23 | $278.9M | — | ||
| Q2 23 | $278.3M | — | ||
| Q1 23 | $295.7M | — |
负债/权益比GUREPROF
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.11× | ||
| Q1 25 | — | 0.09× | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.7M | $-6.6M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流GUREPROF
| Q4 25 | — | $-6.6M | ||
| Q3 25 | $6.7M | $-9.6M | ||
| Q2 25 | $-559.3K | $-13.7M | ||
| Q1 25 | — | $-8.3M | ||
| Q4 23 | $-42.6M | — | ||
| Q3 23 | $-1.1M | — | ||
| Q2 23 | $6.2M | — | ||
| Q1 23 | $4.8M | — |
自由现金流GUREPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | $-16.3M | — | ||
| Q2 23 | $6.2M | — | ||
| Q1 23 | $4.8M | — |
自由现金流率GUREPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | -277.7% | — | ||
| Q2 23 | 77.0% | — | ||
| Q1 23 | 51.6% | — |
资本支出强度GUREPROF
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | 258.3% | — | ||
| Q2 23 | 0.2% | — | ||
| Q1 23 | 0.4% | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GURE
| Bromine | $8.1M | 89% |
| Shandong Shouguang Shenrunfa Marine Chemical Company Limited | $1.4M | 15% |
PROF
暂无分部数据
